Intrinsic OXPHOS limitations underlie cellular bioenergetics in leukemia
Currently there is great interest in targeting mitochondrial oxidative phosphorylation (OXPHOS) in cancer. However, notwithstanding the targeting of mutant dehydrogenases, nearly all hopeful ‘mito-therapeutics’ cannot discriminate cancerous from non-cancerous OXPHOS and thus suffer from a limited th...
Main Authors: | Margaret AM Nelson, Kelsey L McLaughlin, James T Hagen, Hannah S Coalson, Cameron Schmidt, Miki Kassai, Kimberly A Kew, Joseph M McClung, P Darrell Neufer, Patricia Brophy, Nasreen A Vohra, Darla Liles, Myles C Cabot, Kelsey H Fisher-Wellman |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2021-06-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/63104 |
Similar Items
-
Mutations in TIMM50 compromise cell survival in OxPhos‐dependent metabolic conditions
by: Aurelio Reyes, et al.
Published: (2018-10-01) -
Tackling Dysfunction of Mitochondrial Bioenergetics in the Brain
by: Paola Zanfardino, et al.
Published: (2021-08-01) -
Control of the biogenesis of the OXPHOS complexes and their interactions in Saccharomyces cerevisiae
by: Ostojic, Jelena
Published: (2013) -
Metabolic Targeting of Breast Cancer Cells With the 2-Deoxy-D-Glucose and the Mitochondrial Bioenergetics Inhibitor MDIVI-1
by: Federico Lucantoni, et al.
Published: (2018-09-01) -
Mitochondrial OXPHOS Biogenesis: Co-Regulation of Protein Synthesis, Import, and Assembly Pathways
by: Jia Xin Tang, et al.
Published: (2020-05-01)